Despite different cell lines of origin in NPC and PPLELC, the mutational landscape in PPLELC implies similar driver mutations in NF-κB, CDKN2A, JAK/STAT pathway. This evidence concerns the gene CDKN2A and nasopharyngeal carcinoma.